These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 889683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R, Basten A, Nelson DS.
    Int J Cancer; 1975 Mar 15; 15(3):438-50. PubMed ID: 1079792
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H, Muchmore AV, Chused TM, Holden HT, Herberman RB.
    J Immunol; 1975 Jan 15; 114(1 Pt 1):206-10. PubMed ID: 122986
    [Abstract] [Full Text] [Related]

  • 5. Natural cell-mediated immunity to lymphoma cells. I. Characteristics of effector cells in a cytostasis assay in vitro.
    Tufveson G, Riesenfeld I, Rönnblom L, Hedman A, Alm GV.
    J Natl Cancer Inst; 1977 Nov 15; 59(5):1491-7. PubMed ID: 302867
    [Abstract] [Full Text] [Related]

  • 6. Embryonic antigens shared between chemically induced lymphosarcomas and fibrosarcomas of the mouse.
    Ménard S, Colnaghi MI.
    J Natl Cancer Inst; 1975 Feb 15; 54(2):479-81. PubMed ID: 1172784
    [Abstract] [Full Text] [Related]

  • 7. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M, Yamashita T, Gotohda E, Takeichi N, Kodama T, Kobayashi H.
    Int J Cancer; 1978 Jul 15; 22(1):91-7. PubMed ID: 681026
    [Abstract] [Full Text] [Related]

  • 8. [Immunostimulation of the growth of a syngeneic sarcoma primarily induced in mice by simian adenovirus SA7(C8)].
    Ageenko AI, Erkhov VS.
    Vopr Onkol; 1977 Jul 15; 23(8):57-60. PubMed ID: 906408
    [Abstract] [Full Text] [Related]

  • 9. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
    Nelson K, Pollack SB, Hellström KE.
    Int J Cancer; 1975 Aug 15; 16(2):292-300. PubMed ID: 1150355
    [Abstract] [Full Text] [Related]

  • 10. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S, Smith RT.
    Cancer Res; 1973 Aug 15; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract] [Full Text] [Related]

  • 11. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
    Carbone G, Colombo MP, Sensi ML, Cernuschi A, Parmiani G.
    Int J Cancer; 1983 Apr 15; 31(4):483-9. PubMed ID: 6832855
    [Abstract] [Full Text] [Related]

  • 12. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H, Chused TM, Herberman RB, Holden HT, Lavrin DH.
    J Exp Med; 1974 Jun 01; 139(6):1473-87. PubMed ID: 4598016
    [Abstract] [Full Text] [Related]

  • 13. Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.
    Evans R, Booth CG, Spencer F.
    Br J Cancer; 1978 Nov 01; 38(5):583-90. PubMed ID: 310310
    [Abstract] [Full Text] [Related]

  • 14. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW, Kripke ML.
    J Immunol; 1977 Apr 01; 118(4):1483-7. PubMed ID: 66296
    [Abstract] [Full Text] [Related]

  • 15. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb 01; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

  • 16. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R, Alexander P.
    Immunology; 1972 Oct 01; 23(4):615-26. PubMed ID: 5084104
    [Abstract] [Full Text] [Related]

  • 17. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.
    Evans R, Grant CK, Cox H, Steele K, Alexander P.
    J Exp Med; 1972 Nov 01; 136(5):1318-22. PubMed ID: 4117192
    [Abstract] [Full Text] [Related]

  • 18. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA.
    Ann N Y Acad Sci; 1976 Nov 01; 276():272-5. PubMed ID: 829206
    [No Abstract] [Full Text] [Related]

  • 19. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay.
    Gabizon A, Small M, Trainin N.
    Int J Cancer; 1976 Dec 15; 18(6):813-9. PubMed ID: 992909
    [Abstract] [Full Text] [Related]

  • 20. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F, Levy JG, Kilburn DG.
    J Immunol; 1976 Feb 15; 116(2):288-93. PubMed ID: 814160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.